Thrasos

Discovers and develops targeted therapies for the prevention and treatment of severe organ failures.

Launch date

2002

Employees

Market cap

Enterprise valuation

Montreal Quebec (HQ)

Date	Investors	Amount	Round
Oct 2012	SR One Pappas Capital MP Healthcare Venture Management Advanced Technology Ventures Fonds de solidarité FTQ GSK Canada Life Sciences Innovation Fund Lumira Ventures	$35.0m	Series C
Mar 2015	BDC Capital (Canada) SR One Pappas Capital MP Healthcare Venture Management Advanced Technology Ventures Fonds de solidarité FTQ Lumira Ventures Business Development Bank of Canada (BDC)	$21.0m	Series D
Total Funding		CAD76.4m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Thrasos